Baltimore, MD
Chelation Therapy clinics in Baltimore
Chelation therapy in Baltimore is offered by a small set of integrative and naturopathic clinics, typically for documented heavy metal toxicity confirmed by provocation or baseline testing. Common agents include calcium disodium EDTA, DMPS, DMSA, and deferoxamine, each with specific binding profiles for lead, mercury, arsenic, or iron.
Most Baltimore chelation providers are MDs or DOs with ACAM training, and in some states naturopathic doctors within their licensed scope. Protocols vary from 10-session courses for basic detoxification to longer 30-session cardiovascular protocols modeled on the TACT trial. Pricing is cash-pay in almost every case, and no insurance covers off-label chelation.
With verified chelation therapy clinics on Regenerated.com in Baltimore, Maryland, patients can compare provider credentials, testing protocols, and agent selection. Regenerated.com does not recommend chelation for cardiovascular disease or autism. The FDA has only approved specific agents for specific heavy metal poisoning diagnoses. Chelation outside that narrow indication is off-label, and in the wrong hands it has caused deaths.
Whole Body Healthcare
- Ozone Therapy
- IV Therapy
- Arthritis Treatment
- Chelation Therapy
- Migraine Treatment
Regulatory context
A note on Maryland's chelation therapy rules.
The FDA has approved a narrow set of chelating agents for specific heavy metal toxicities. Calcium disodium edetate (CaNa2EDTA, Versenate) is approved for symptomatic lead poisoning, succimer (Chemet, DMSA) for pediatric lead poisoning at blood lead levels above 45 mcg/dL, deferoxamine (Desferal) and deferasirox (Exjade) for chronic iron overload, and dimercaprol (BAL) for arsenic, gold, and acute lead poisoning. Use of EDTA chelation for cardiovascular disease was studied in the NIH-funded TACT trial (2013) with controversial findings and remains not FDA-approved for that indication. Chelation for autism spectrum disorder is not evidence-based and has been linked to pediatric deaths. The FDA issued a 2010 sweep of warning letters to compounders marketing OTC chelation products with unapproved disease claims.
-
Maryland Medical Practice Act, Md. Code, Health Occupations, Title 14
Governs MD and DO practice in Maryland. -
Maryland Naturopathic Doctor Licensing Act, Md. Code, Health Occupations, Title 14, Subtitle 5C
Maryland licenses NDs with a scope that does not include most IV chelation.
The Maryland Board of Physicians has investigated chelation practitioners for marketing claims and informed consent failures. Maryland is home to NIH and FDA headquarters, and the board has been particularly attentive to evidence-based practice expectations. The state's ND scope is restrictive and largely excludes IV chelation. Maryland enforcement reflects national caution following the 2005 Pittsburgh pediatric chelation death.
Chelation Therapy in Baltimore, answered.
Explore related care